Related Experiment Video
Updated: Jun 22, 2026
09:00
TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
Published on: April 13, 2021
Data protection in grid-based multicentric clinical trials: killjoy or confidence-building measure?
Marian Arning1, Nikolaus Forgó, Tina Krügel
1Institute for Legal Informatics of the Leibniz University of Hannover, Königsworther Platz 1, 30167 Hannover, Germany.
Summary
A new data protection framework for multicentric genetic research ensures patient privacy and researcher efficiency. Pseudonymization, partner contracts, and a central authority make data effectively anonymous, safeguarding participants.
Area of Science:
- Genetics
- Bioethics
- Data Privacy
Background:
- Multicentric genetic research involves sensitive patient data.
- Protecting participant privacy is crucial for ethical research.
- Researchers require secure and efficient data handling.
Purpose of the Study:
- To establish a robust data protection framework for multicentric genetic research.
- To ensure patient privacy and enhance researcher working conditions.
- To comply with ethical guidelines and data security standards.
Main Methods:
- Implementing pseudonymization for all genetic data.
- Establishing legally binding contracts with project partners for data usage and security.
- Creating a central data protection authority to oversee compliance and act as a participant contact point.
- Obtaining specific informed consent from each participant.
Main Results:
- The framework renders genetic data de facto anonymous, potentially exempting it from direct data protection legislation.
- Participant privacy is protected through pseudonymization and consent.
- Researcher working conditions are improved by clear data handling protocols.
Conclusions:
- The proposed data protection framework effectively balances patient privacy with research needs.
- This model enhances data security and ethical compliance in large-scale genetic studies.
- Informed consent serves as a critical ethical safeguard and failsafe mechanism.
Related Concept Videos
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:23Ethical Standards II
Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy and...
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy and...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...